Clinical Trial

Physiological and Psychological Profiles

Completed
View on ClinicalTrials.gov →
Summary
The participation of women in high-impact sports such as rugby and basketball has been steadily increasing in Saudi Arabia. These sports are known for their physical demands and competitive nature, which have heightened the incidence of sports-related injuries. Understanding the predictive factors for these injuries is critical for developing preventive strategies, reducing long-term health consequences, and reducing healthcare burdens. Therefore, this study aims to identify the predictive effect of physiological factors (e.g., muscle strength, anaerobic power, oxygen consumption) and psychological factors (e.g., self-efficacy, resilience) on sports injuries among female athletes in Saudi Arabia, particularly focusing on those involved in rugby and basketball. A prospective cross-sectional design will be employed, involving a total of 30 female athletes aged 18-35 years actively participating in rugby and basketball. Data will be collected at the lifestyle research center through a series of physiological assessments, including maximal oxygen consumption, anaerobic power testing, isokinetic muscle strength testing, and psychological evaluations using validated questionnaires. The findings are expected to provide insights into the specific factors that increase injury risk among Saudi female athletes, offering targeted strategies for injury prevention. These strategies aim not only to minimize injuries but also to reduce associated healthcare costs, thereby supporting the sustainable growth of women's sports in Saudi Arabia. Ultimately, this study seeks to contribute to the broader objectives of Vision 2030 by promoting a vibrant sports culture and enhancing public health.
Protocol Amendment History 1 change
critical Trial completed 2026-08-04
Trial Details
NCT Number NCT07026383
Lead Sponsor Princess Nourah Bint Abdulrahman University
Conditions Healthy Volunteer, Female
Enrollment 60 participants
Start Date 2025-01-25
Primary Completion 2025-09-25 (estimated)
Study Completion 2026-03-20 (estimated)
Updated on ClinicalTrials.gov 2026-08-03